Cosette Pharmaceuticals

Cosette Pharmaceuticals is a private, commercial-stage generic drug company headquartered in Cranford, New Jersey. The company leverages its fully integrated infrastructure to develop and market a diverse portfolio of generic and OTC products, with recent successes including a first-to-file generic launch with 180-day exclusivity. Its strategy centers on portfolio expansion through strategic partnerships and internal R&D, focusing on therapeutic areas like dermatology while building out contract development and manufacturing (CDMO) capabilities. Cosette emphasizes operational efficiency, supply chain reliability, and a culture of innovation to compete in the complex generic pharmaceuticals market.

Integrated generic drug development and manufacturing infrastructure with expertise in complex formulations (topicals, suppositories, oral liquids) and a growing CDMO (Contract Development and Manufacturing Organization) service arm.

Cosette competes in the highly fragmented generic pharmaceuticals market against large global players (e.g., Teva, Viatris, Sun Pharma) and numerous agile smaller companies. Its competitive differentiation is based on its integrated model, focus on complex formulations and supply reliability, and strategic pursuit of first-to-file exclusivity opportunities.